JULIE BRAY: Open Payments
NPI 1174613145 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$471 in 24 payments from 12 companies in 2025. Trend: 2023 $497 · 2024 $497 · 2025 $471
Food & beverage: $471
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $136 |
| Janssen Biotech, Inc. | 4 | $91 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Genentech USA, Inc. | 2 | $33 |
| Gilead Sciences, Inc. | 1 | $33 |
| ABBVIE INC. | 1 | $28 |
| PFIZER INC. | 1 | $22 |
| Eisai Inc. | 1 | $22 |
| Geron Corporation | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: PLUVICTO, RYBREVANT, TALVEY, IMFINZI, IMBRUVICA, SCEMBLIX, PADCEV, Lenvima.
Industry payments across OH — which companies pay providers there.
